NRGN and early-onset autosomal dominant Alzheimer disease: Similarly, in a longitudinal study of 37 cognitively normal individuals and 65 patients with Alzheimer’s disease within the memory-clinic-based Amsterdam Dementia Cohort, baseline CSF neurogranin levels in patients with the disease were significantly higher than in cognitively normal participants [263].